GreyBrook logotype
Contact Us

Health

Investment Strategy

Unlike our real estate strategies, Greybrook’s healthcare portfolio consists of making very selective and focused investments in commercial stage medical device and healthcare services companies, as principals. We bring to bear our expertise to help source and evaluate unique business opportunities and build effective management teams. We have demonstrated a proven track record of helping businesses unlock their true growth potential.

From our early beginnings as pioneers in laser vision correction in the 1990’s to our more recent active investments in companies who share our commitment to advancing human health, we selectively invest our own proprietary capital and leverage our management team’s deep expertise and relationships that have been acquired over decades in the industry.

We are opportunistic healthcare investors who invest in ideas that inspire us and in which we can meaningfully influence outcomes by playing a strategic and active role alongside strong management teams.

Investments in Focus

Greenbrook TMS (NASDAQ: GBNH, TSX: GTMS) is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders in the U.S.

阅读更多

Delos is a global wellness pioneer that is working with organizations and industry leaders around the world to improve the health and wellness aspects of their buildings and indoor environments to positively impact the health outcomes of people in those environments.

阅读更多
Greybrook

Operating through 128 company-operated treatment centres, Greenbrook TMS is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy in the U.S. TMS Therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 620,000 TMS treatments to over 17,000 patients struggling with depression.

Since founding Greenbrook in 2011, Greybrook continues to play a key role supporting management and helping to unlock the firm’s growth potential through our deep expertise in commercializing health care services.

View Site
Greybrook

Greybrook invested in Delos, a New York based wellness real estate and technology company and partnered to establish its presence in Canada through the formation of Delos Canada. The firm’s mission is to help Canadian businesses, real estate owners, and the public sector advance human health and well-being through more thoughtful design and improvement of the buildings and interior spaces we inhabit every day.

We play a critical role in supporting the Delos Canada team in working with the real estate development community, leading Canadian business and all levels of government to help implement Delos’ evidence-based productions and solutions in offices, schools, long-term care facilities, public venues, and new residential communities across Canada.

Read More

Health Care Investments

Partner Greybrook
Partner Greybrook
Partner Greybrook
Partner Greybrook
Partner Greybrook